Furthermore, reductions in the amounts of both GSK3β and β-catenin lead to a negative signal cascade during the CRC cell cycle, reducing both CDK1 and Cyclin B1 and resulting in G2 cell cycle arrest (Figure 7A). The gene discussed is CDK1; the disease is colorectal carcinoma.